These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21410745)

  • 1. Quantitative immunohistochemical fingerprinting of adhesion/growth-regulatory galectins in salivary gland tumours: divergent profiles with diagnostic potential.
    Remmelink M; de Leval L; Decaestecker C; Duray A; Crompot E; Sirtaine N; André S; Kaltner H; Leroy X; Gabius HJ; Saussez S
    Histopathology; 2011 Mar; 58(4):543-56. PubMed ID: 21410745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
    Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
    J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
    Meer S; Altini M
    Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
    Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
    Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 expression in salivary gland tumours.
    de Araújo VC; Furuse C; Cury PR; Altemani A; de Araújo NS
    Oral Oncol; 2008 May; 44(5):439-45. PubMed ID: 17826306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microRNA signature for the differential diagnosis of salivary gland tumors.
    Denaro M; Navari E; Ugolini C; Seccia V; Donati V; Casani AP; Basolo F
    PLoS One; 2019; 14(1):e0210968. PubMed ID: 30682201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours.
    Alves FA; Pires FR; De Almeida OP; Lopes MA; Kowalski LP
    Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.
    Abd Raboh NM; Hakim SA
    Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique expression of MUC3, MUC5AC and cytokeratins in salivary gland carcinomas.
    Lee JH; Lee JH; Kim A; Kim I; Chae YS
    Pathol Int; 2005 Jul; 55(7):386-90. PubMed ID: 15982212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of the melanoma antigen gene (MAGE) in making the differential diagnosis between pleomorphic adenoma and adenoid cystic carcinoma.
    Park JH; Do NY; Han SI; Lim SC
    J Otolaryngol Head Neck Surg; 2012 Feb; 41(1):20-9. PubMed ID: 22498264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma.
    Penner CR; Folpe AL; Budnick SD
    Mod Pathol; 2002 Jul; 15(7):687-91. PubMed ID: 12118104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
    Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
    J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumors.
    Ashkavandi ZJ; Najvani AD; Tadbir AA; Pardis S; Ranjbar MA; Ashraf MJ
    Asian Pac J Cancer Prev; 2013; 14(6):3479-82. PubMed ID: 23886132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
    Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
    Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 immunoprofile in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands.
    Ferrazzo KL; Alves SM; Santos E; Martins MT; de Sousa SM
    Oral Oncol; 2007 Jul; 43(6):580-5. PubMed ID: 16996782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of methylation patterns of cancer genes in salivary gland tumors.
    Williams MD; Chakravarti N; Kies MS; Maruya S; Myers JN; Haviland JC; Weber RS; Lotan R; El-Naggar AK
    Clin Cancer Res; 2006 Dec; 12(24):7353-8. PubMed ID: 17189407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human α-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours.
    Winter J; Pantelis A; Kraus D; Reckenbeil J; Reich R; Jepsen S; Fischer HP; Allam JP; Novak N; Wenghoefer M
    BMC Cancer; 2012 Oct; 12():465. PubMed ID: 23050799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Catenin expression in benign and malignant salivary gland tumors.
    Chandrashekar C; Angadi PV; Krishnapillai R
    Int J Surg Pathol; 2011 Aug; 19(4):433-40. PubMed ID: 20034989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of quantitative p63 immunostaining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis.
    Ramer N; Wu H; Sabo E; Ramer Y; Emanuel P; Orta L; Burstein DE
    Cancer; 2010 Jan; 116(1):77-83. PubMed ID: 19877114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical distribution of CD9 in parotid gland tumors.
    Sakamoto K; Nakamura Y; Nakashima T
    Auris Nasus Larynx; 2004 Mar; 31(1):49-55. PubMed ID: 15041054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.